The customer reported that when the patient was switched to this freedom driver at the set beat rate of 133, the driver displayed a beat rate of 129 and the patient's displayed fill volumes dropped from 40-50s to 20-30s.The customer also reported that the patient was switched to a companion 2 driver to monitor him for approximately one hour, and then he was switched to another freedom driver.There was no reported adverse patient impact.This alleged failure mode poses a low risk to the patient because it did not prevent the freedom driver from performing its life-sustaining functions.The freedom driver will be returned to syncardia for investigation.The results of the investigation will be provided in a follow-up mdr.
|
The customer reported that when the patient was switched to this freedom driver at the set beat rate of 133, the driver displayed a beat rate of 129 and the patient's displayed fill volumes dropped from 40-50s to 20-30s.The customer also reported that the patient was switched to a companion 2 driver to monitor him for approximately one hour, and then he was switched to another freedom driver.There was no reported adverse patient impact.The freedom driver was returned to syncardia for evaluation.Visual inspection of the external and internal components revealed no abnormalities.Review of the alarm history (eeprom) did not reveal any new alarms that were recorded while the driver was supporting the patient, and the customer did not report any alarms.The driver was tested and passed all test requirements, which included nominal normotensive and hypertensive patient simulator settings, with no anomalies or unintended alarms.The driver was then tested for an additional 48 hours, and there was no variation in beat rate or decrease in fill volume.The investigation determined that the freedom driver performed as intended, and there was no evidence of a device malfunction.It is possible that the variation in beat rate and drop in fill volume were the result of the patient's condition at the time of the customer experience.The freedom driver was serviced and passed all final performance testing.The reported issue posed a low risk to the patient because it did not prevent the freedom driver from performing its life-sustaining functions.This issue will continue to be monitored and trended as part of the customer experience process.Syncardia has completed its evaluation of this complaint and is closing this file.
|